Description
Developer of a drug delivery mechanism. The company offers an antiseptic mechanism that increases the efficiency in ophthalmic surgeries and preoperative antisepsis.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 01-Apr-2016 | Completed | Out of Business | |||
2. Grant | 01-Jun-2014 | 0000 | Completed | Startup | ||
1. Early Stage VC | 01-Jan-2014 | Completed | Startup |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Clint Matthews | Chief Executive Officer and Co-Founder | ||
Kyle Rood | President and Co-Founder |